GlassScriptPhysician profile
Byron Layne Stapleton
NPI 1053610923
$7,231.70
in general payments reported to CMS, 2019-2025
13 companies · $6,984 in 2025
The $6,984 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.24 · 2022: $15.72 · 2023: $106 · 2024: $47.36 · 2025: $6,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,418 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,418.09 |
| Food and Beverage | $219.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,918.09 | 2025 | |
| Ethicon US, LLC | $62.04 | 2019-2024 | Enseal X1, Echelon Flex, Harmonic |
| Reprise Biomedical, INC. | $45.27 | 2023-2025 | Miro3d |
| Csl Behring | $37.97 | 2023 | Kcentra |
| Novo Nordisk INC | $37.56 | 2023-2025 | Wegovy |
| Lsi Solutions INC | $23.25 | 2019 | |
| Acera Surgical, INC. | $19.00 | 2025 | Restrata Wound Matrix |
| Kci USA, INC. | $17.88 | 2023 | Prevena, V.A.C. Veraflo |
| Icu Medical INC | $16.08 | 2024 | Tracheostomy |
| Currax Pharmaceuticals LLC | $14.61 | 2023 | Contrave |
| Boston Scientific Corporation | $13.85 | 2024 | Spyglass Discover |
| Olympus America INC. | $13.84 | 2019 | |
| Davol INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.